US Stock MarketDetailed Quotes

CHGCY Chugai Pharmaceutical (ADR)

Watchlist
  • 23.750
  • +0.040+0.17%
15min DelayTrading Nov 4 15:00 ET
78.16BMarket Cap30.88P/E (TTM)

Chugai Pharmaceutical (ADR) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations
41.86%170.27B
49.54%168.53B
-1.91%110.14B
-19.57%462.72B
-27.20%117.72B
13.10%120.03B
4.50%112.7B
-43.76%112.28B
22.32%575.35B
4.27%161.71B
Change In working capital
347.60%28.95B
-2,165.67%-111.07B
-64.48%44.11B
171.26%130.63B
106.41%12.76B
-78.36%-11.69B
-90.27%5.38B
474.55%124.19B
-120.53%-183.31B
-222.64%-198.86B
Cash from discontinued investing activities
Operating cash flow
295.09%123.64B
-44.23%70.65B
-21.01%100.91B
68.29%409.93B
559.99%124.21B
24.25%31.3B
-26.72%126.67B
76.10%127.75B
-12.89%243.58B
-128.44%-27B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale
-92.09%-17.52B
-17.48%-20.61B
51.08%-12.47B
14.58%-52.6B
96.35%-440M
-28.75%-9.12B
-112.11%-17.55B
25.40%-25.49B
5.16%-61.58B
-53.12%-12.05B
Net intangibles purchase and sale
98.00%-9M
-5.24%-1.08B
-100.42%-62M
258.96%12.85B
-854.55%-420M
75.69%-451M
71.15%-1.03B
664.09%14.75B
-17.21%-8.08B
-109.52%-44M
Net investment purchase and sale
-291.27%-20.77B
-1,457.18%-119.55B
16.91%-20.57B
101.29%979M
160.60%6.07B
128.12%10.86B
129.17%8.81B
-1,005.71%-24.75B
-61.07%-76.08B
-7.51%-10.01B
Net other investing changes
----
----
----
150.00%1M
--3M
---1M
---2M
200.00%1M
---2M
----
Cash from discontinued investing activities
Investing cash flow
-1,986.14%-37.57B
-1,371.96%-140.65B
8.84%-32.24B
74.36%-37.29B
125.64%5.64B
104.20%1.99B
77.26%-9.56B
-4.09%-35.37B
-22.31%-145.47B
-28.25%-22.02B
Financing cash flow
Cash flow from continuing financing activities
Net common stock issuance
390.91%54M
-48.48%17M
-40.00%72M
-8.05%217M
381.82%53M
-57.69%11M
-37.74%33M
-17.81%120M
-24.84%236M
-80.00%11M
Cash dividends paid
-3.14%-67.46B
-19.47%-540M
0.62%-64.96B
4.79%-131.59B
12.80%-368M
-5.40%-65.41B
22.20%-452M
13.03%-65.37B
-40.12%-138.22B
-31.88%-422M
Net other financing activities
----
--2M
-200.00%-1M
---5M
---4M
-300.00%-2M
--0
200.00%1M
----
----
Cash from discontinued financing activities
Financing cash flow
-3.15%-69.51B
-9.76%-2.6B
0.61%-66.87B
4.33%-139.33B
2.34%-2.3B
-5.32%-67.38B
2.95%-2.37B
12.47%-67.28B
-35.60%-145.64B
20.97%-2.36B
Net cash flow
Beginning cash position
7.87%393.76B
86.87%462.86B
106.45%458.67B
-17.02%222.17B
20.91%331.34B
1.31%365.02B
7.47%247.69B
-17.02%222.17B
26.10%267.75B
42.35%274.04B
Current changes in cash
148.58%16.57B
-163.26%-72.59B
-92.84%1.8B
590.92%233.3B
348.29%127.55B
60.46%-34.1B
-10.63%114.75B
165.51%25.1B
-189.18%-47.52B
-168.67%-51.37B
Effect of exchange rate changes
-1,609.48%-6.37B
35.49%3.49B
466.59%2.39B
65.14%3.2B
56.18%-220M
1,858.33%422M
79.78%2.58B
-59.07%422M
-8.88%1.94B
-218.12%-502M
End cash Position
21.92%403.96B
7.87%393.76B
86.87%462.86B
106.45%458.67B
106.45%458.67B
20.91%331.34B
1.31%365.02B
7.47%247.69B
-17.02%222.17B
-17.02%222.17B
Free cash flow
378.62%104.95B
-54.84%48.41B
-12.11%88.38B
94.77%335.67B
371.70%105.99B
34.76%21.93B
-32.72%107.19B
181.26%100.56B
-16.65%172.34B
-144.78%-39.01B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations 41.86%170.27B49.54%168.53B-1.91%110.14B-19.57%462.72B-27.20%117.72B13.10%120.03B4.50%112.7B-43.76%112.28B22.32%575.35B4.27%161.71B
Change In working capital 347.60%28.95B-2,165.67%-111.07B-64.48%44.11B171.26%130.63B106.41%12.76B-78.36%-11.69B-90.27%5.38B474.55%124.19B-120.53%-183.31B-222.64%-198.86B
Cash from discontinued investing activities
Operating cash flow 295.09%123.64B-44.23%70.65B-21.01%100.91B68.29%409.93B559.99%124.21B24.25%31.3B-26.72%126.67B76.10%127.75B-12.89%243.58B-128.44%-27B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale -92.09%-17.52B-17.48%-20.61B51.08%-12.47B14.58%-52.6B96.35%-440M-28.75%-9.12B-112.11%-17.55B25.40%-25.49B5.16%-61.58B-53.12%-12.05B
Net intangibles purchase and sale 98.00%-9M-5.24%-1.08B-100.42%-62M258.96%12.85B-854.55%-420M75.69%-451M71.15%-1.03B664.09%14.75B-17.21%-8.08B-109.52%-44M
Net investment purchase and sale -291.27%-20.77B-1,457.18%-119.55B16.91%-20.57B101.29%979M160.60%6.07B128.12%10.86B129.17%8.81B-1,005.71%-24.75B-61.07%-76.08B-7.51%-10.01B
Net other investing changes ------------150.00%1M--3M---1M---2M200.00%1M---2M----
Cash from discontinued investing activities
Investing cash flow -1,986.14%-37.57B-1,371.96%-140.65B8.84%-32.24B74.36%-37.29B125.64%5.64B104.20%1.99B77.26%-9.56B-4.09%-35.37B-22.31%-145.47B-28.25%-22.02B
Financing cash flow
Cash flow from continuing financing activities
Net common stock issuance 390.91%54M-48.48%17M-40.00%72M-8.05%217M381.82%53M-57.69%11M-37.74%33M-17.81%120M-24.84%236M-80.00%11M
Cash dividends paid -3.14%-67.46B-19.47%-540M0.62%-64.96B4.79%-131.59B12.80%-368M-5.40%-65.41B22.20%-452M13.03%-65.37B-40.12%-138.22B-31.88%-422M
Net other financing activities ------2M-200.00%-1M---5M---4M-300.00%-2M--0200.00%1M--------
Cash from discontinued financing activities
Financing cash flow -3.15%-69.51B-9.76%-2.6B0.61%-66.87B4.33%-139.33B2.34%-2.3B-5.32%-67.38B2.95%-2.37B12.47%-67.28B-35.60%-145.64B20.97%-2.36B
Net cash flow
Beginning cash position 7.87%393.76B86.87%462.86B106.45%458.67B-17.02%222.17B20.91%331.34B1.31%365.02B7.47%247.69B-17.02%222.17B26.10%267.75B42.35%274.04B
Current changes in cash 148.58%16.57B-163.26%-72.59B-92.84%1.8B590.92%233.3B348.29%127.55B60.46%-34.1B-10.63%114.75B165.51%25.1B-189.18%-47.52B-168.67%-51.37B
Effect of exchange rate changes -1,609.48%-6.37B35.49%3.49B466.59%2.39B65.14%3.2B56.18%-220M1,858.33%422M79.78%2.58B-59.07%422M-8.88%1.94B-218.12%-502M
End cash Position 21.92%403.96B7.87%393.76B86.87%462.86B106.45%458.67B106.45%458.67B20.91%331.34B1.31%365.02B7.47%247.69B-17.02%222.17B-17.02%222.17B
Free cash flow 378.62%104.95B-54.84%48.41B-12.11%88.38B94.77%335.67B371.70%105.99B34.76%21.93B-32.72%107.19B181.26%100.56B-16.65%172.34B-144.78%-39.01B
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Japanese Companies
Japanese Companies
Intraday+0.33%